期刊文献+

基于基因免疫制备抗人绒毛膜促性腺激素β亚基单克隆抗体及其特性研究

Preparation of the anti-human chorionic gonadotrophin β-subunit monoclonal antibodies based on the genetic immunization with recombinant plasmid and characterization of its biological properties
下载PDF
导出
摘要 用真核表达人绒毛膜促性腺激素β亚基((human chorionic gonadotrophinβ,hCGβ)的重组质TR421-hCGβ免疫BALB/c小鼠,采用B淋巴细胞杂交瘤技术进行细胞融合,ELISA法筛选阳性细胞株,经过多次的克隆化培养,最终获得10株持续、稳定分泌抗hCGβ单克隆抗体的杂交瘤细胞株。随机抽取6H1杂交瘤细胞进行抗体的制备、纯化及免疫学特性的分析。间接ELISA法证明6H1单抗属于IgG2a亚类。Western blot证明6H1单克隆抗体可以特异性结合hCGβ,间接免疫荧光和流式细胞仪等结果表明,6H1单克隆抗体能够不同程度的结合不同来源的肿瘤细胞膜上表达的hCGβ分子,为进一步研究其生物学功能奠定了物质基础。 The eukaryotic expression vector TR321 hCGβ encoding the β subunit of human chorionic gonadotrophin (hCGβ) was used to immunize BALB/c for the prepration of corresponding monoclonal antibodies. By means of the routine hybridoma technique for B lymphocytes of cell fusion, repeated screening by ELISA and multiple cell cloning, 10 hybridoma cell lines, capable of secreting anti-hCGβ monoclonal antibodies continously, were thus obtained, in which 6H1 hybridoma was random ly selected to prepare the specific antibody, to purify the secreted antibodies and to analyse its immunologic properties. As demonstrated by indirect ELISA assay, the 6H1 monoclonal antibody was isotyped to be IgG2a. In Western blot assay it was demonstrated that this monoclonal antibody could specifically bind to hCGβ. It was also demonstrated that 6H1 monoclonal antibody could recognize the hCGβ molecules expressed on various tumor cell lines of different origins.
出处 《现代免疫学》 CAS CSCD 北大核心 2007年第3期212-216,共5页 Current Immunology
基金 上海市医学领军人才资助项目(LJ06011)
关键词 HCGΒ 基因免疫 杂交瘤 单克隆抗体 hCGβ genetic immunization hybridoma monoclonal antibody
  • 相关文献

参考文献13

  • 1Gailani S,Chu TM,Nussbaum A,et al.Human chorionic gonadotrophin (HCG) in nontrophoblastic neoplasms[J].Cancer,1976,38(4):1684-1686.
  • 2Hotakainen K,Haglund C,Paju A,et al.Chorionic gonadotropin beta-subunit and core fragment in bladder cancer:mRNA and protein expression in urine,serum and tissue[J].Eur Urol,2002,41(6):677-685.
  • 3Gillott DJ,lles RK,Chard T.The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines[J].Br J Cancer,1996,73(3):323-326.
  • 4Baselga J.Phase I and Ⅱ clinical trials of trastuzumab[J].Ann Oncol,2001,12 suppl 1:S49-S55.
  • 5Dillman RO.Magic bullets at last! Finally--approval of a monoclonal antibody for the treatment of cancer[J].Cancer Biother Radiopharm,1997,12(4):223-225.
  • 6王立新,徐薇,关庆东,熊思东.ehCGβ肿瘤基因疫苗诱生抗体的抗肿瘤作用[J].中国肿瘤生物治疗杂志,2003,10(4):239-242. 被引量:2
  • 7陶然,石云杰,孙中文,马泓冰,徐颖,程钢,孙玮丽,周立峰,邱玉华,张学光.鼠抗人B7-2单克隆抗体的研制及生物学特性研究[J].现代免疫学,2006,26(3):203-207. 被引量:9
  • 8Louhimo J,Carpelan-Holmstrom M,Alfthan H,et al.Serum HCG beta,CA 72-4 and CEA are independent prognostic factors in colorectal cancer[J].Int J Cancer,2002,101(6):545-548.
  • 9Acevedo HF,Hartsock RJ,Maroom JC.Detection of membrane-associated human chorionic gonadotrophin and its subunits on human cultured cancer cells of the nervous system[J].Cancer Detect Prev,1997,21(4):295-303.
  • 10Acevedo HF,Hartsock RJ.Metastatic phenotype correlates with high expression of membrane-associated complete-human chorionic gonadotrophin in vivo[J].Cancer,1996,78(11):2388-2399.

二级参考文献16

  • 1Sharpe AH,Freeman GJ.The B7-CD28 superfamily[J].Nat Rev Immunol,2002,2(2):116-126.
  • 2Orabona C,Grohmann U,Belladonna ML,et al.CD28 induces immunostimulatory signals in dentritic cells via CD80 and CD86[J].Nat Immunol,2004,5(11):1134-1142.
  • 3Bour-Jordan H,Bluestone JA.CD28 function:a balance of costimulatory and regulatory signals[J].J Clin Immunol,2002,16:117-121.
  • 4Zheng Y,Manzotti CN,Liu M,et al.CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells[J].J Immunol,2004,172:2778-2784.
  • 5Pentcheva-Hoang T,Egen JG,Wojnoonaki K,et al.B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse[J].Immunology,2004,21(9):401-413.
  • 6Lenschow DJ,Whlunas TL,Bluestone JA.CD28/B7 system of T cell costimulation[J].Annu Rev Immunol,1996,14:233-258.
  • 7Thomas J,Nguyen P,Peach P,et al.In vivo B7-2 blockade inhibits CD4+T cell activation,whereas CD80 blockade potentiates CD8^+T cell activation and CTL effector function[J].J Immunol,2002,268:786-792.
  • 8Singh S,Sahdev S,Vohra H,et al.Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma[J].J Biol Chem,2002,277:7766-7775.
  • 9Shi HZ,Xie ZF,Deng JM,et al.Soluble B7-2 protein in serum samples of patients with asthma[J].Thorax,2004,59:870-875.
  • 10Martinez-Escribano JA,Hernandez-Caselles T,Campillo JA,et al.Changes in the number of CD80,CD86,and CD28 peripheral blood lymphocytes have prognostic value in melanoma patients[J].Hum Immunol,2003,64(8):796-801.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部